Madrid/Heidelberg (ots) -- Agreement follows a global licence agreement signed with QIAGEN in 2012. - First non-exclusive licence agreement for a new amplification buffer developed by Professor Salas at the CSIC laboratory. Spanish-German biotech company SYGNIS Pharma AG (Frankfurt: LIO1; ISIN: DE000A1RFM03, Prime Standard segment of the German Stock Exchange) has signed a licence agreement…





Recent Comments